This week in Trumponomics: The coronavirus denier
Trump can’t tame a virus that poses the most serious threat to his presidency so far. …read more […]
Trump can’t tame a virus that poses the most serious threat to his presidency so far. …read more […]
The World Health Organization’s warning on Friday that the coronavirus was now a “global level” risk intensified fears for the global economy. …read more […]
Unfortunately for some shareholders, the Marathon Oil (NYSE:MRO) share price has dived 33% in the last thirty days… …read more […]
It’s been a bloody week for the market. But it’s important to remember that the S&P 500 is down only about 3% so far in 2020. And believe it or not, the market is still up 10% over the last year.
I think we could be headed a lot lower. Even before the novel coronavirus happened, the market was fragile. Profits were slowing, as was the market before central banks lowered rates and brought back quantitative easing (QE).
In my view, the Fed’s low rates and easy money were the only things keeping the U.S. bull market alive (more on that here).
Low …read more […]
A new note from Morgan Stanley shows three possible scenarios for the economy. We are currently headed for the second scenario. …read more […]
The market has been particularly volatile over the last six sessions. What should investors do?
Follow Alexander Green’s time-tested advice for wealth creation.
It’s certainly been an interesting seven days for the stock market.
Last Wednesday, the S&P 500 hit a new all-time high. But over the last seven sessions, it has plummeted 16%.
The Dow had its biggest point drop in history yesterday. And it is on track for an equally large drop today.
This has already been the single worst week for the market since the financial crisis.
The Dow, the Nasdaq and the S&P 500 are all in correction territory, along with markets …read more […]
The market has been particularly volatile over the last six sessions. What should investors do?
Follow Alexander Green’s time-tested advice for wealth creation.
It’s certainly been an interesting seven days for the stock market.
Last Wednesday, the S&P 500 hit a new all-time high. But over the last seven sessions, it has plummeted 16%.
The Dow had its biggest point drop in history yesterday. And it is on track for an equally large drop today.
This has already been the single worst week for the market since the financial crisis.
The Dow, the Nasdaq and the S&P 500 are all in correction territory, along with markets …read more […]
(Bloomberg) — Apple Inc. Chief Executive Officer Tim Cook suggested the iPhone maker wouldn’t make any quick moves out of China in light of interruptions due to the coronavirus and called the situation a “temporary condition.”“We’re talking about adjusting some knobs, not some sort of wholesale, fundamental change,” he said in an interview aired Friday on Fox Business.Apple’s China-focused supply chain is facing two major tests — first from a trade war between the U.S. and China and more recently from manufacturing outages spurred by the spread of the virus across the world’s most populous nation.Read more: Apple Outlook Cut …read more […]
(Bloomberg Opinion) — Warren Buffett is credited with that old saying about receding tides and embarrassed skinny-dippers. In Occidental Petroleum Corp.’s case, the lack of swimwear is one problem, but so is the anchor tied around its ankle. Part of that anchor is the old sage himself.Oxy, as it is known, just reported results for its first full quarter since acquiring Anadarko Petroleum Corp. In that bruising takeover battle against Chevron Corp., Berkshire Hathaway Inc. provided a crucial $10 billion check allowing Oxy to avoid a shareholder vote. It came at a steep cost of, among other goodies, an 8% …read more […]
The historic stock market rout may have a few hidden winners as the coronavirus crisis ricochets across the globe. …read more […]
Stocks have crashed due to the coronavirus outbreak. Is it time to go all into stocks now at cheaper prices? …read more […]
Firm’s largest trades of the 4th quarter Continue reading… …read more […]
It’s been a sad week for Sarepta Therapeutics, Inc. (NASDAQ:SRPT), who’ve watched their investment drop 13% to US$108… …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.